NCT06234280View on ClinicalTrials.gov

Korean Multicenter Registry of ELUVIA Stent for Femoropopliteal Artery Disease

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

May 11, 2018

Primary Completion Date

June 7, 2023

Study Completion Date

December 31, 2023

Conditions

Symptomatic Peripheral Artery Disease With Femoropopliteal LesionsModerate or Severe Claudication (Rutherford Category 2 or 3)Critical Limb Ischemia (Rutherford Category 4 or 5)

Interventions

DEVICE

Implantation of Eluvia stent

Trial Locations (1)

Unknown

Division of Cardiology, Yonsei Cardiovascular Hospital, Yonsei University College of Medicine, Seoul

All Listed Sponsors

lead

Yonsei University

OTHER

NCT06234280 - Korean Multicenter Registry of ELUVIA Stent for Femoropopliteal Artery Disease | Biotech Hunter | Biotech Hunter